- Increased expenditure due to the Red Sea crisis leading to supply chain disruptions
- Moderate pricing pressure on Rx products in the US
Marksans Pharma Limited
Greenhouse gas emissions & sustainability report data
In its 2023-24 reporting, Marksans Pharma Limited disclosed greenhouse gas emissions of 23.1K tCO2e. By scope: Scope 1: 23.1K tCO2e; Scope 2: 0 tCO2e; Scope 3: 0 tCO2e. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
23.1K tCO2e
2023-24
Water Usage
78.4K KL
2023-24
Waste
28.755 tons
2023-24
Energy Use
82.3M MJ
2023-24
📊 Emissions by Scope (2023-24)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 23.1K tCO2e |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 0 tCO2e |
| Scope 3 | Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.). | 0 tCO2e |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023-24 | 23.1K tCO2e |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Minimized environmental footprint through energy-efficient technologies and waste reduction initiatives
- Implemented effective measures to reduce water consumption
- Recycled 15.199 metric tons of waste
🌱 ESG Focus Areas
Environmental SustainabilitySocial ResponsibilityGovernance